Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penthrox for acute pain in pediatric minor trauma
NCT03215056Phase 3Completed
- Sponsor
- Medical Developments International
- Start
- Aug 2017
- Primary completion
- Jun 2022
- Modality
- Allosteric Modulators
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in acute pain comparing Methoxyflurane with Placebo (2 arms). Primary endpoint: Difference in pain intensity measured by change from baseline in VAS pain scores. Started Aug 2017; status: completed.
02
Drugs
methoxyflurane
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03215056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03215056.